Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study

被引：0
|
作者：
Jaymin B. Morjaria
Alan Rigby
Alyn H. Morice
机构：
[1] Hull York Medical School,Centre for Cardiovascular & Metabolic Research
[2] University of Hull,Department of Respiratory Medicine
[3] Castle Hill Hospital,undefined
[4] Royal Brompton & Harefield NHS Trust,undefined
[5] Harefield Hospital,undefined
来源：
Lung | 2017年 / 195卷
关键词：
Fluticasone; Inhaled corticosteroids; Tiotropium; UPLIFT; Pneumonia; COPD;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：281 / 288
页数：7
相关论文
共 50 条
  • [41] Discontinuation of Inhaled Corticosteroids in COPD and the Risk Reduction of Pneumonia
    Suissa, Samy
    Coulombe, Janie
    Ernst, Pierre
    CHEST, 2015, 148 (05) : 1177 - 1183
  • [42] INHALED CORTICOSTEROID USE AND RISK OF DIABETES MELLITUS
    Oh, Jee Youn
    Sim, Jae Kyeom
    Choi, Jong Hyun
    Min, Kyung Hoon
    Hur, Gyu Young
    Lee, Seung Heon
    Lee, Sung Yong
    Shin, Chol
    Shim, Jae Jeong
    Kang, Kyung Ho
    Kim, Je Hyeoung
    RESPIROLOGY, 2014, 19 : 75 - 75
  • [43] Inhaled and nasal corticosteroid use and the risk of fracture
    Suissa, S
    Baltzan, M
    Kremer, R
    Ernst, P
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (01) : 83 - 88
  • [44] Evaluation of systemic corticosteroid use in the management of acute COPD exacerbations.
    Vondracek, SF
    Tran, L
    PHARMACOTHERAPY, 2004, 24 (10): : 1465 - 1465
  • [45] Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
    Magnussen, Helgo
    Disse, Bernd
    Rodriguez-Roisin, Roberto
    Kirsten, Anne
    Watz, Henrik
    Tetzlaff, Kay
    Towse, Lesley
    Finnigan, Helen
    Dahl, Ronald
    Decramer, Marc
    Chanez, Pascal
    Wouters, Emiel F. M.
    Calverley, Peter M. A.
    Chia, M.
    Peters, M.
    Polasek, J.
    Sajkov, D.
    Seale, P.
    Wheatley, J.
    Bedert, L.
    Driesen, P.
    Fievez, P.
    Flemale, A.
    Martinot, J-B
    Mentens, Y.
    Ninane, V
    Peche, R.
    Plas, B.
    van Zandweghe, L.
    Adalberto, R.
    Carmo Moreira, M. A.
    Fritscher, C.
    Gondim, H.
    Jardim, J. R. B.
    Dancheva, A.
    Kostov, K.
    Lllieva-Fartunova, V
    Metev, H.
    Osmanliev, D.
    Palaveev, Rashkov K.
    Taseva, M.
    Troshanova, E.
    Bai, C.
    Baiqiang, C.
    Li, H.
    Lin, Y.
    Tang, Y.
    Wu, Y.
    Xin, J.
    Yao, W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (14): : 1285 - 1294
  • [46] The effect of the indicated use of β-blockers on the risk of COPD exacerbations: the Rotterdam Study
    Karimi, Leila
    Brusselle, Guy
    Lahousse, Lies
    De Nocker, Phebe
    Stricker, Bruno H.
    Verhamme, Katia M. C.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [47] Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain
    Miravitlles, Marc
    Roman-Rodriguez, Miguel
    Ribera, Xavier
    Ritz, John
    Izquierdo, Jose Luis
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 245 - 258
  • [48] Inhaled corticosteroid use and its association with Pseudomonas aeruginosa infection in COPD
    Shafiek, Hanaa
    Verdu, Javier
    Lopez-Causape, Carla
    Iglesias, Amanda
    Ramon-Clar, Lluisa
    Juan, Carlos
    Toledo-Pons, Nuria
    Oliver, Antonio
    Cosio Piqueras, Borja Garcia
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [49] Inhaled Corticosteroids as a Risk Factor for Hospitalisation with Pneumonia in COPD Patients
    Ronn, C. P.
    Sivapalan, P.
    Ekloef, J.
    Ulrik, C. S.
    Jensen, J. S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [50] Effect of inhaled corticosteroid use in smokers and non-smokers with COPD
    Sonnex, K.
    Knaggs, R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 22 - 23
12345